Allstate Corp: Argus Research cuts to hold from buy

Allstate Corp (ALL) recently experienced a downgrade in its analyst rating as Argus Research revised its recommendation from "Buy" to "Hold," citing evolving market conditions and valuation concerns. The stock currently trades at $239.61, reflecting a 3.46% increase on the day, supported by strong earnings performance and a projected net income of $10.28 billion in 2025. Despite this, the firm’s analysts believe the stock may be approaching a valuation level that warrants caution.

The company maintains a market capitalization of $61.68 billion and an enterprise value of $70.48 billion, with a 52-week trading range between $190 and $239.61. Over the past three months, Allstate has seen a drawdown of -8.23%, indicating recent volatility. The stock offers a dividend yield of 1.8%, with the most recent payout of $1.08 per share on June 1, 2026.

Wall Street sentiment remains cautiously optimistic, with 46.5% of analysts maintaining a "Buy" rating and a consensus price target of $237.40. However, the downgrade from Argus Research highlights potential risks, including margin pressures in auto insurance and catastrophe-related losses. Investors are advised to monitor these factors as they could influence the stock’s near-term performance.